Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>The purpose of this study was to investigate risk factors of in‐hospital mortality and vascular complications after coronary artery bypass grafting (CABG), particularly the effect of different glycemic control levels on outcomes in patients with and without previous evidence of diabetes.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>A total of 8682 patients with and without previous diabetes undergoing CABG were categorized into strict, moderate, and liberal glucose control groups according to their mean blood glucose control level <7.8 mmol/L, 7.8 to 10.0 mmol/L, and ≥10.0 mmol/l after in‐hospital CABG.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The patients with previous diabetes had higher rates of in‐hospital mortality (1.3% vs 0.4%, <i>P<</i>0.001) and major complications (7.0% vs 4.8%, <i>P</i><0.001) than those without diabetes. Current diabetes was significantly associated with a higher risk of in‐hospital mortality (odds ratio [OR]=3.14, 95% confidence interval [CI]1.87‐5.27) and major complications (OR=1.49, 95% CI 1.24‐1.80), and smoking and higher low‐density lipoprotein cholesterol (LDL‐c) levels showed similar results. Among patients with previous diabetes, strict glucose control was significantly associated with an increased risk of in‐hospital mortality (OR=8.32, 95% CI 3.95‐17.51) compared with moderate glucose control. Nevertheless, among non‐previous diabetic patients with stress hyperglycemia, strict glucose control led to a lower risk of major complications (OR=0.71, 95% CI 0.52‐0.98). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Diabetes status, smoking, and LDL‐c levels were modifiable risk factors of both in‐hospital mortality and major complications after CABG. Strict glucose control was associated with an increased risk of in‐hospital mortality among patients with diabetes, whereas it reduced the risk of major complications among non‐previous diabetic patients.</p></section>

Heavy top-quark searches in the dilepton mode at the Fermilab Tevatron.

Use of octyl-2-cyanoacrylate for skin closure in facial plastic surgery.

Glycosylated Hemoglobin (HbA1C) as a Predictor of Early Postoperative Outcomes After Coronary Artery Bypass Grafting: A Single-Center Observational Study

Increased risk of adverse cardiovascular events by strict glycemic control after percutaneous coronary intervention (HbA1c < 6.5% at 2 years) in type 2 diabetes mellitus combined with acute coronary syndrome: a 5-years follow-up study

Hemoglobin A1c and long-term mortality in patients undergoing coronary angiography: the ECAD registry

The role of hemoglobin A1c as a predictor of major adverse cardiovascular events in patients with type 2 diabetes mellitus after percutaneous coronary intervention: a case-cohort study

Association between HbA1c levels with severity of coronary artery disease and short-term outcomes of acute ST-elevation myocardial infarction in nondiabetic patients

Glycemic control and risk factors for in‐hospital mortality and vascular complications after coronary artery bypass grafting in patients with and without preexisting diabetes

Correlation of Hba1c Levels With Clinical Outcomes in Patients with Acute Coronary Syndrome

Impact of diabetes on short-term outcomes in patients undergoing coronary artery bypass grafting surgery in acute coronary syndrome

Glycosylated Hemoglobin Levels And Clinical Outcomes In Nondiabetic Patients With Coronary Artery Disease A Meta-Analysis

HbA1c and Coronary Heart Disease Risk among Diabetic Patients.

U-shaped association between HbA1c and all-cause mortality in CVD patients with diabetes

Elevated Hemoglobin A1C Level And Revisional Bariatric Surgery Complications

Implications of Baseline Glycemic Control by Plasma Glycated Hemoglobin A1c on Adverse Outcomes in Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus:Results from the PROMISE Study

Association of Longitudinal Values of Glycated Hemoglobin With Cardiovascular Events in Patients With Type 2 Diabetes and Multivessel Coronary Artery Disease

Impact of Diabetes on Coronary Artery Bypass Grafting Outcome

Hemoglobin A1c Levels Are Related to Patency and Adverse Limb Events in Diabetics After Revascularization

Analysis of Angiographic Patterns in Acute Coronary Syndrome Patients With Diabetes Mellitus: Correlation With HbA1c Levels

The association between glycated hemoglobin levels and long-term prognosis in patients with diabetes and triple-vessel coronary disease across different age groups: A cohort study

Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support